Collectively, the findings herein establish a Tryp-derived uremic metabolite/AHR/Pdk4 axis as a critical regulator of skeletal muscle mitochondrial function in CKD, when fueled by pyruvate, and provide evidence that interventions that disrupt this axis can improve muscle mitochondrial function. Here, AHR is linked to chronic kidney disease.